O. Alejandro Balbin
Magnetic Resonance Imaging Institute for Biomedical Research(US)Novartis (United States)(US)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Cancer-related molecular mechanisms research, Gene expression and cancer classification, RNA modifications and cancer, Lung Cancer Treatments and Mutations
Most-Cited Works
- → High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response(2015)1,424 cited
- → Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression(2011)1,031 cited
- → Capmatinib in MET Exon 14–Mutated or MET -Amplified Non–Small-Cell Lung Cancer(2020)977 cited
- → Personalized Oncology Through Integrative High-Throughput Sequencing: A Pilot Study(2011)635 cited
- → The landscape of antisense gene expression in human cancers(2015)189 cited
- → Transcriptome meta-analysis of lung cancer reveals recurrent aberrations in NRG1 and Hippo pathway genes(2014)152 cited
- → Reconstructing targetable pathways in lung cancer by integrating diverse omics data(2013)90 cited
- → Ceritinib plus Nivolumab in Patients with Advanced ALK-Rearranged Non–Small Cell Lung Cancer: Results of an Open-Label, Multicenter, Phase 1B Study(2019)76 cited
- → Non-coding RNA LINC00857 is predictive of poor patient survival and promotes tumor progression via cell cycle regulation in lung cancer(2016)57 cited
- → A Phase Ib/II, open-label, multicenter study of INC280 (capmatinib) alone and in combination with buparlisib (BKM120) in adult patients with recurrent glioblastoma(2019)49 cited